Mebutamate
美布氨酯
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameMebutamate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMedpointe Pharm
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMedPointe Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications